IFP Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.08M | Buy |
25,344
+7,196
| +40% | +$391K | 0.02% | 703 |
|
|
2026
Q1 | $1.14M | Buy |
18,148
+1,061
| +6% | +$84.9K | 0.02% | 634 |
|
|
2025
Q4 | $1.63M | Sell |
17,087
-3,013
| -15% | -$295K | 0.04% | 476 |
|
|
2025
Q3 | $1.96M | Sell |
20,100
-1,888
| -9% | -$196K | 0.05% | 387 |
|
|
2025
Q2 | $2.37M | Buy |
21,988
+5,313
| +32% | +$538K | 0.07% | 324 |
|
|
2025
Q1 | $1.68M | Buy |
16,675
+8,570
| +106% | +$863K | 0.05% | 400 |
|
|
2024
Q4 | $724K | Buy |
8,105
+1,200
| +17% | +$106K | 0.02% | 612 |
|
|
2024
Q3 | $579K | Buy |
6,905
+471
| +7% | +$37.1K | 0.02% | 639 |
|
|
2024
Q2 | $495K | Buy |
6,434
+1,292
| +25% | +$94.6K | 0.02% | 660 |
|
|
2024
Q1 | $352K | Sell |
5,142
-311
| -6% | -$20K | 0.02% | 730 |
|
|
2023
Q4 | $315K | Buy |
5,453
+427
| +8% | +$22.8K | 0.01% | 748 |
|
|
2023
Q3 | $265K | Buy |
5,026
+1,132
| +29% | +$59.4K | 0.01% | 836 |
|
|
2023
Q2 | $211K | Buy |
3,894
+1,585
| +69% | +$82.8K | 0.01% | 993 |
|
|
2023
Q1 | $70.6K | Sell |
2,309
-4,294
| -65% | -$202K | ﹤0.01% | 1416 |
|
|
2022
Q4 | $217K | Sell |
6,603
-846
| -11% | -$36.6K | 0.01% | 1309 |
|
|
2022
Q3 | $241K | Buy |
7,449
+1,110
| +18% | +$44.5K | 0.01% | 1298 |
|
|
2022
Q2 | $205K | Hold |
6,339
| – | – | 0.01% | 1272 |
|
|
2022
Q1 | $205K | Buy |
6,339
+5,595
| +752% | +$242K | 0.01% | 1272 |
|
|
2021
Q4 | $33K | Sell |
744
-56
| -7% | -$2.35K | ﹤0.01% | 1722 |
|
|
2021
Q3 | $36K | Sell |
800
-218
| -21% | -$9.64K | ﹤0.01% | 1713 |
|
|
2021
Q2 | $44K | Sell |
1,018
-16,195
| -94% | -$681K | ﹤0.01% | 1580 |
|
|
2021
Q1 | $668K | Buy |
17,213
+1,053
| +7% | +$39.9K | 0.01% | 449 |
|
|
2020
Q4 | $582K | Buy |
16,160
+1,928
| +14% | +$69.5K | 0.02% | 463 |
|
|
2020
Q3 | $543K | Buy |
14,232
+13,127
| +1,188% | +$506K | 0.03% | 410 |
|
|
2020
Q2 | $39K | Buy |
1,105
+165
| +18% | +$5.94K | ﹤0.01% | 1317 |
|
|
2020
Q1 | $31K | Sell |
940
-283
| -23% | -$11.1K | ﹤0.01% | 1317 |
|
|
2019
Q4 | $56K | Sell |
1,223
-766
| -39% | -$32.1K | ﹤0.01% | 1203 |
|
|
2019
Q3 | $81K | Buy |
+1,989
| New | +$84.3K | 0.01% | 1158 |
|
|
2019
Q1 | – | Sell |
-4,586
| Closed | -$159K | – | 2488 |
|
|
2018
Q4 | $159K | Sell |
4,586
-820
| -15% | -$29.7K | 0.01% | 961 |
|
|
2018
Q3 | $208K | Sell |
5,406
-143
| -3% | -$5K | 0.01% | 1057 |
|
|
2018
Q2 | $181K | Sell |
5,549
-3,388
| -38% | -$102K | 0.01% | 1111 |
|
|
2018
Q1 | $222K | Hold |
8,937
| – | – | 0.01% | 941 |
|
|
2017
Q4 | $222K | Sell |
8,937
-2,799
| -24% | -$77.2K | 0.01% | 943 |
|
|
2017
Q3 | $342K | Buy |
11,736
+2,659
| +29% | +$73.4K | 0.01% | 863 |
|
|
2017
Q2 | $252K | Buy |
9,077
+2,114
| +30% | +$56.1K | 0.01% | 992 |
|
|
2017
Q1 | $173K | Sell |
6,963
-619
| -8% | -$15.1K | 0.01% | 1193 |
|
|
2016
Q4 | $164K | Sell |
7,582
-2,344
| -24% | -$51.1K | 0.01% | 1154 |
|
|
2016
Q3 | $236K | Sell |
9,926
-346
| -3% | -$8.25K | 0.01% | 922 |
|
|
2016
Q2 | $240K | Buy |
+10,272
| New | +$222K | 0.01% | 885 |
|
|
2016
Q1 | – | Sell |
-4,014
| Closed | -$74K | – | 2481 |
|
|
2015
Q4 | $74K | Buy |
+4,014
| New | +$71.9K | 0.01% | 1345 |
|
Other funds holding BSX
IFP Advisors's BSX Position: Q2 2026 in Review
IFP Advisors increased its Boston Scientific (BSX) stake by 40% in Q2 2026, buying an estimated $391K and bringing the position to 25,344 shares worth $1.08M. The position accounts for 0.02% of the portfolio, ranked #703.
IFP Advisors first reported a position in BSX in Q4 2015 and has held it in 40 quarters since. The position peaked at $2.37M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- IFP Advisors held 25,344 shares of Boston Scientific worth $1.08M as of Q2 2026.
- IFP Advisors bought 7,196 Boston Scientific shares in Q2 2026, an estimated $391K.
- Boston Scientific made up 0.02% of IFP Advisors's portfolio in Q2 2026, its #703 holding.
- IFP Advisors first reported a position in Boston Scientific in Q4 2015 and has held it in 40 quarters since.
- IFP Advisors's Boston Scientific position peaked at $2.37M in Q2 2025.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.